Effect of ELX/TEZ/IVA treatment on lung ventilation in children with cystic fibrosis – comprehensive assessment using spirometry, MBW, structural and functional lung MRI
C. Streibel (Bern, Switzerland), C. Willers (Bern, Switzerland), O. Pusterla (Basel, Switzerland), G. Bauman (Basel, Switzerland), O. Bieri (Basel, Switzerland), E. Stranzinger (Bern, Switzerland), B. Brabandt (Bern, Switzerland), P. Latzin (Bern, Switzerland), E. Kieninger (Bern, Switzerland)
Source: International Congress 2022 – Monitoring the effect of therapy with CFTR modulators
Session: Monitoring the effect of therapy with CFTR modulators
Session type: Oral Presentation
Number: 1623
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Streibel (Bern, Switzerland), C. Willers (Bern, Switzerland), O. Pusterla (Basel, Switzerland), G. Bauman (Basel, Switzerland), O. Bieri (Basel, Switzerland), E. Stranzinger (Bern, Switzerland), B. Brabandt (Bern, Switzerland), P. Latzin (Bern, Switzerland), E. Kieninger (Bern, Switzerland). Effect of ELX/TEZ/IVA treatment on lung ventilation in children with cystic fibrosis – comprehensive assessment using spirometry, MBW, structural and functional lung MRI. 1623
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|